Inspire Medical Systems Gross Margin 2017-2024 | INSP
Current and historical gross margin for Inspire Medical Systems (INSP) over the last 10 years. The current gross profit margin for Inspire Medical Systems as of September 30, 2024 is %.
| Inspire Medical Systems Gross Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Gross Profit | Gross Margin |
| 2024-09-30 | $0.76B | $0.64B | 84.66% |
| 2024-06-30 | $0.71B | $0.60B | 84.70% |
| 2024-03-31 | $0.66B | $0.56B | 84.57% |
| 2023-12-31 | $0.63B | $0.53B | 84.48% |
| 2023-09-30 | $0.57B | $0.48B | 84.21% |
| 2023-06-30 | $0.53B | $0.44B | 83.65% |
| 2023-03-31 | $0.47B | $0.39B | 83.69% |
| 2022-12-31 | $0.41B | $0.34B | 83.78% |
| 2022-09-30 | $0.35B | $0.29B | 84.15% |
| 2022-06-30 | $0.30B | $0.26B | 85.33% |
| 2022-03-31 | $0.26B | $0.22B | 85.50% |
| 2021-12-31 | $0.23B | $0.20B | 85.41% |
| 2021-09-30 | $0.20B | $0.17B | 85.07% |
| 2021-06-30 | $0.18B | $0.15B | 85.14% |
| 2021-03-31 | $0.13B | $0.11B | 85.07% |
| 2020-12-31 | $0.12B | $0.10B | 85.22% |
| 2020-09-30 | $0.10B | $0.08B | 85.42% |
| 2020-06-30 | $0.08B | $0.07B | 83.95% |
| 2020-03-31 | $0.09B | $0.07B | 83.91% |
| 2019-12-31 | $0.08B | $0.07B | 82.93% |
| 2019-09-30 | $0.07B | $0.06B | 80.56% |
| 2019-06-30 | $0.06B | $0.05B | 81.25% |
| 2019-03-31 | $0.06B | $0.05B | 80.70% |
| 2018-12-31 | $0.05B | $0.04B | 80.39% |
| 2018-09-30 | $0.04B | $0.04B | 81.82% |
| 2018-06-30 | $0.04B | $0.03B | 81.58% |
| 2018-03-31 | $0.03B | $0.03B | 81.82% |
| 2017-12-31 | $0.03B | $0.02B | 82.14% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $5.669B | $0.625B |
| Inspire Medical Systems Inc. is a medical technology company. It focused on the development and commercialization of solutions for obstructive sleep apnea. The company's proprietary Inspire therapy is a neurostimulation technology which provides treatment for moderate to severe obstructive sleep apnea. Inspire Medical Systems Inc.is based in Minnesota, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Hims & Hers Health (HIMS) | United States | $5.506B | 140.00 |
| Tempus AI (TEM) | United States | $5.393B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $2.799B | 0.00 |
| Enovis (ENOV) | United States | $2.475B | 16.78 |
| Privia Health (PRVA) | United States | $2.357B | 196.40 |
| Azenta (AZTA) | United States | $2.286B | 122.05 |
| Omnicell (OMCL) | United States | $2.053B | 67.15 |
| 10x Genomics (TXG) | United States | $1.718B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.568B | 0.00 |
| Schrodinger (SDGR) | United States | $1.486B | 0.00 |
| Phreesia (PHR) | United States | $1.464B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.846B | 0.00 |
| Standard BioTools (LAB) | United States | $0.651B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.563B | 0.00 |
| Talkspace (TALK) | United States | $0.529B | 0.00 |
| Definitive Healthcare (DH) | United States | $0.476B | 82.40 |
| Health Catalyst (HCAT) | United States | $0.446B | 0.00 |
| TruBridge (TBRG) | United States | $0.297B | 86.52 |
| Pulmonx (LUNG) | United States | $0.257B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.209B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.114B | 0.00 |
| American Well (AMWL) | United States | $0.108B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.090B | 0.00 |
| HeartBeam (BEAT) | United States | $0.063B | 0.00 |
| CareCloud (CCLD) | United States | $0.062B | 0.00 |
| Outset Medical (OM) | United States | $0.061B | 0.00 |
| 111 (YI) | China | $0.054B | 0.00 |
| Zepp Health (ZEPP) | China | $0.043B | 0.00 |
| Zhongchao (ZCMD) | China | $0.043B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.041B | 0.00 |
| Movano (MOVE) | United States | $0.035B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.018B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.016B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.016B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.014B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.012B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.008B | 0.00 |
| Precipio (PRPO) | United States | $0.008B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.006B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.005B | 0.00 |
| Syra Health (SYRA) | United States | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |